# Leidos Holdings, Inc.: financial statements, quarterly

LDOS · NYSE · CIK 1336920 · [Technology](/sectors/technology.md) · fiscal year ends Jan 1

Pages: [Overview](/companies/ldos.md) · [Financials](/companies/ldos/financials.md) · [Filings](/companies/ldos/filings.md) · [Insiders](/companies/ldos/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ldos/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-29) | Q4 FY2023 (2023-12-29) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2025-01-03) | Q1 FY2025 (2025-04-04) | Q2 FY2025 (2025-07-04) | Q3 FY2025 (2025-10-03) | Q4 FY2025 (2026-01-02) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,897](/filings/0001336920-24-000054.md) | [3,950 d](/filings/0001336920-26-000030.md) | [3,951](/filings/0001336920-25-000014.md) | [4,107](/filings/0001336920-25-000034.md) | [4,169](/filings/0001336920-25-000060.md) | [4,349 d](/filings/0001336920-26-000030.md) | [4,228](/filings/0001336920-26-000169.md) | [4,233](/filings/0001336920-26-000246.md) | [4,449](/filings/0001336920-25-000060.md) | [4,197 d](/filings/0001336920-26-000030.md) | [4,383](/filings/0001336920-26-000169.md) | [4,548](/filings/0001336920-26-000246.md) |
| Cost of revenue | $m | [3,334](/filings/0001336920-24-000054.md) | [3,385 d](/filings/0001336920-26-000030.md) | [3,337](/filings/0001336920-25-000014.md) | [3,427](/filings/0001336920-25-000034.md) | [3,428](/filings/0001336920-25-000060.md) | [3,672 d](/filings/0001336920-26-000030.md) | [3,488](/filings/0001336920-26-000169.md) | [3,471](/filings/0001336920-26-000246.md) | [3,648](/filings/0001336920-25-000060.md) | [3,468 d](/filings/0001336920-26-000030.md) | [3,639](/filings/0001336920-26-000169.md) | [3,741](/filings/0001336920-26-000246.md) |
| Selling, general and administrative | $m | [239](/filings/0001336920-24-000054.md) | [233 d](/filings/0001336920-26-000030.md) | [226](/filings/0001336920-25-000014.md) | [231](/filings/0001336920-25-000034.md) | [247](/filings/0001336920-25-000060.md) | [279 d](/filings/0001336920-26-000030.md) | [230](/filings/0001336920-26-000169.md) | [217](/filings/0001336920-26-000246.md) | [286](/filings/0001336920-25-000060.md) | [266 d](/filings/0001336920-26-000030.md) | [223](/filings/0001336920-26-000169.md) | [283](/filings/0001336920-26-000246.md) |
| Operating income | $m | [(336)](/filings/0001336920-24-000054.md) | [361 d](/filings/0001336920-26-000030.md) | [415](/filings/0001336920-25-000014.md) | [475](/filings/0001336920-25-000034.md) | [516](/filings/0001336920-25-000060.md) | [421 d](/filings/0001336920-26-000030.md) | [530](/filings/0001336920-26-000169.md) | [571](/filings/0001336920-26-000246.md) | [535](/filings/0001336920-25-000060.md) | [473 d](/filings/0001336920-26-000030.md) | [508](/filings/0001336920-26-000169.md) | [514](/filings/0001336920-26-000246.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [8.0](/filings/0001336920-24-000054.md) | [80.0 d](/filings/0001336920-26-000030.md) | [85.0](/filings/0001336920-25-000014.md) | [102](/filings/0001336920-25-000034.md) | [108](/filings/0001336920-25-000060.md) | [93.0 d](/filings/0001336920-26-000030.md) | [113](/filings/0001336920-26-000169.md) | [125](/filings/0001336920-26-000246.md) | [115](/filings/0001336920-25-000060.md) | [94.0 d](/filings/0001336920-26-000030.md) | [94.0](/filings/0001336920-26-000169.md) | [95.0](/filings/0001336920-26-000246.md) |
| Net income | $m | [(399)](/filings/0001336920-24-000054.md) | [229 d](/filings/0001336920-26-000030.md) | [284](/filings/0001336920-25-000014.md) | [322](/filings/0001336920-25-000034.md) | [364](/filings/0001336920-25-000060.md) | [284 d](/filings/0001336920-26-000030.md) | [363](/filings/0001336920-26-000169.md) | [391](/filings/0001336920-26-000246.md) | [367](/filings/0001336920-25-000060.md) | [327 d](/filings/0001336920-26-000030.md) | [328](/filings/0001336920-26-000169.md) | [354](/filings/0001336920-26-000246.md) |
| Diluted EPS | $ per share | [(2.91)](/filings/0001336920-24-000054.md) | not reported | [2.07](/filings/0001336920-25-000014.md) | [2.37](/filings/0001336920-25-000034.md) | [2.68](/filings/0001336920-25-000060.md) | not reported | [2.77](/filings/0001336920-26-000169.md) | [3.01](/filings/0001336920-26-000246.md) | [2.82](/filings/0001336920-25-000060.md) | not reported | [2.56](/filings/0001336920-26-000169.md) | [2.81](/filings/0001336920-26-000246.md) |
| Basic EPS | $ per share | [(2.91)](/filings/0001336920-24-000054.md) | not reported | [2.09](/filings/0001336920-25-000014.md) | [2.39](/filings/0001336920-25-000034.md) | [2.72](/filings/0001336920-25-000060.md) | not reported | [2.79](/filings/0001336920-26-000169.md) | [3.03](/filings/0001336920-26-000246.md) | [2.87](/filings/0001336920-25-000060.md) | not reported | [2.60](/filings/0001336920-26-000169.md) | [2.81](/filings/0001336920-26-000246.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-29) | FY2023 (2023-12-29) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | FY2024 (2025-01-03) | Q1 FY2025 (2025-04-04) | Q2 FY2025 (2025-07-04) | Q3 FY2025 (2025-10-03) | FY2025 (2026-01-02) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.8](/filings/0001336920-24-000054.md) | [0.6](/filings/0001336920-26-000030.md) | [0.5](/filings/0001336920-25-000014.md) | [0.7](/filings/0001336920-25-000034.md) | [1.1](/filings/0001336920-25-000060.md) | [0.8](/filings/0001336920-26-000030.md) | [0.8](/filings/0001336920-26-000169.md) | [0.9](/filings/0001336920-26-000246.md) | [1.0](/filings/0001336920-25-000060.md) | [1.1](/filings/0001336920-26-000246.md) | [0.5](/filings/0001336920-26-000169.md) | [0.7](/filings/0001336920-26-000246.md) |
| Current assets | $bn | [4.0](/filings/0001336920-23-000061.md) | [4.0](/filings/0001336920-25-000006.md) | [4.2](/filings/0001336920-24-000036.md) | [4.2](/filings/0001336920-24-000049.md) | [4.7](/filings/0001336920-24-000054.md) | [4.3](/filings/0001336920-26-000030.md) | [4.5](/filings/0001336920-25-000014.md) | [4.8](/filings/0001336920-25-000034.md) | [4.8](/filings/0001336920-25-000060.md) | [4.8](/filings/0001336920-26-000246.md) | [4.4](/filings/0001336920-26-000169.md) | [5.2](/filings/0001336920-26-000246.md) |
| Total assets | $bn | [12.8](/filings/0001336920-23-000061.md) | [12.7](/filings/0001336920-25-000006.md) | [12.8](/filings/0001336920-24-000036.md) | [12.9](/filings/0001336920-24-000049.md) | [13.3](/filings/0001336920-24-000054.md) | [13.0](/filings/0001336920-26-000030.md) | [13.2](/filings/0001336920-25-000014.md) | [13.5](/filings/0001336920-25-000034.md) | [13.5](/filings/0001336920-25-000060.md) | [13.5](/filings/0001336920-26-000246.md) | [15.4](/filings/0001336920-26-000169.md) | [15.6](/filings/0001336920-26-000246.md) |
| Current liabilities | $bn | [3.0](/filings/0001336920-23-000061.md) | [3.0](/filings/0001336920-25-000006.md) | [3.1](/filings/0001336920-24-000036.md) | [3.5](/filings/0001336920-24-000049.md) | [3.8](/filings/0001336920-24-000054.md) | [3.6](/filings/0001336920-26-000030.md) | [3.0](/filings/0001336920-25-000014.md) | [2.9](/filings/0001336920-25-000034.md) | [3.0](/filings/0001336920-25-000060.md) | [2.8](/filings/0001336920-26-000246.md) | [3.2](/filings/0001336920-26-000169.md) | [3.2](/filings/0001336920-26-000246.md) |
| Total liabilities | $bn | [8.6](/filings/0001336920-23-000061.md) | [8.4](/filings/0001336920-25-000006.md) | [8.5](/filings/0001336920-24-000036.md) | [8.4](/filings/0001336920-24-000049.md) | [8.7](/filings/0001336920-24-000054.md) | [8.6](/filings/0001336920-26-000030.md) | [8.9](/filings/0001336920-25-000014.md) | [8.8](/filings/0001336920-25-000034.md) | [8.6](/filings/0001336920-25-000060.md) | [8.5](/filings/0001336920-26-000246.md) | [10.3](/filings/0001336920-26-000169.md) | [10.3](/filings/0001336920-26-000246.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | [0.0](/filings/0001336920-23-000061.md) | [0.0](/filings/0001336920-25-000006.md) | [0.0](/filings/0001336920-24-000036.md) | [0.6](/filings/0001336920-24-000049.md) | [0.6](/filings/0001336920-24-000054.md) | [0.6](/filings/0001336920-26-000030.md) | [0.1](/filings/0001336920-25-000014.md) | [0.1](/filings/0001336920-25-000034.md) | [0.0](/filings/0001336920-25-000060.md) | [0.0](/filings/0001336920-26-000246.md) | [0.3](/filings/0001336920-26-000169.md) | [0.0](/filings/0001336920-26-000246.md) |
| Short-term borrowings | $bn | [0.0](/filings/0001336920-23-000061.md) | [0.0](/filings/0001336920-24-000008.md) | [0.0](/filings/0001336920-24-000036.md) | [0.0](/filings/0001336920-24-000049.md) | [0.0](/filings/0001336920-24-000054.md) | [0.0](/filings/0001336920-26-000030.md) | [0.0](/filings/0001336920-25-000014.md) | [0.0](/filings/0001336920-25-000034.md) | [0.0](/filings/0001336920-25-000060.md) | [0.0](/filings/0001336920-26-000246.md) | [0.3](/filings/0001336920-26-000169.md) | [0.0](/filings/0001336920-26-000246.md) |
| Shareholders' equity | $bn | [4.1](/filings/0001336920-23-000061.md) | [4.2](/filings/0001336920-25-000006.md) | [4.3](/filings/0001336920-24-000036.md) | [4.5](/filings/0001336920-24-000049.md) | [4.6](/filings/0001336920-24-000054.md) | [4.4](/filings/0001336920-26-000030.md) | [4.3](/filings/0001336920-25-000014.md) | [4.7](/filings/0001336920-25-000034.md) | [4.9](/filings/0001336920-25-000060.md) | [4.9](/filings/0001336920-26-000246.md) | [5.0](/filings/0001336920-26-000169.md) | [5.3](/filings/0001336920-26-000246.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings, us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-29) | Q4 FY2023 (2023-12-29) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2025-01-03) | Q1 FY2025 (2025-04-04) | Q2 FY2025 (2025-07-04) | Q3 FY2025 (2025-10-03) | Q4 FY2025 (2026-01-02) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [795 d](/filings/0001336920-24-000054.md) | [326 d](/filings/0001336920-26-000030.md) | [113](/filings/0001336920-25-000014.md) | [381 d](/filings/0001336920-25-000034.md) | [647 d](/filings/0001336920-25-000060.md) | [294 d](/filings/0001336920-26-000030.md) | [58.0](/filings/0001336920-26-000169.md) | [486 d](/filings/0001336920-26-000246.md) | [711 d](/filings/0001336920-25-000060.md) | [495 d](/filings/0001336920-26-000030.md) | [301](/filings/0001336920-26-000169.md) | [793 d](/filings/0001336920-26-000246.md) |
| Capital expenditure | $m | [50.0 d](/filings/0001336920-24-000054.md) | [78.0 d](/filings/0001336920-26-000030.md) | [17.0](/filings/0001336920-25-000014.md) | [23.0 d](/filings/0001336920-25-000034.md) | [23.0 d](/filings/0001336920-25-000060.md) | [86.0 d](/filings/0001336920-26-000030.md) | [22.0](/filings/0001336920-26-000169.md) | [29.0 d](/filings/0001336920-26-000246.md) | [31.0 d](/filings/0001336920-25-000060.md) | [43.0 d](/filings/0001336920-26-000030.md) | [31.0](/filings/0001336920-26-000169.md) | [32.0 d](/filings/0001336920-26-000246.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [0.0](/filings/0001336920-24-000054.md) | [200 d](/filings/0001336920-26-000030.md) | [150](/filings/0001336920-25-000014.md) | [100](/filings/0001336920-25-000034.md) | [200](/filings/0001336920-25-000060.md) | [400 d](/filings/0001336920-26-000030.md) | [0.0](/filings/0001336920-26-000169.md) | [0.0](/filings/0001336920-26-000246.md) | [100](/filings/0001336920-25-000060.md) | [300 d](/filings/0001336920-26-000030.md) | [200](/filings/0001336920-26-000169.md) | [66.0](/filings/0001336920-26-000246.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-29) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q1 FY2025 (2025-04-04) | Q2 FY2025 (2025-07-04) | Q3 FY2025 (2025-10-03) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [138](/filings/0001336920-23-000061.md) | [138](/filings/0001336920-24-000036.md) | [138](/filings/0001336920-24-000049.md) | [137](/filings/0001336920-24-000054.md) | [137](/filings/0001336920-25-000014.md) | [136](/filings/0001336920-25-000034.md) | [136](/filings/0001336920-25-000060.md) | [131](/filings/0001336920-26-000169.md) | [130](/filings/0001336920-26-000246.md) | [130](/filings/0001336920-25-000060.md) | [128](/filings/0001336920-26-000169.md) | [126](/filings/0001336920-26-000246.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 125,492,209 at 2026-07-28, from the cover of the [10-Q filed 2026-08-04](/filings/0001336920-26-000246.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.